Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
Status:
Recruiting
Trial end date:
2025-06-10
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about the safety and tolerability of an
experimental drug, Venetoclax, when it is given along with Decitabine in subjects diagnosed
with acute myeloid leukemia (AML).